Protection by catatoxic steroids against phenindione overdosage.
D000731:Androstanes / Q000627:therapeutic use*; D000818:Animals; D003900:Desoxycorticosterone / Q000627:therapeutic use; D004121:Dimethyl Sulfoxide; D004958:Estradiol / Q000627:therapeutic use*; D005032:Ethylestrenol / Q000627:therapeutic use; D006474:Hemorrhagic Disorders / Q000139:chemically induced / Q000517:prevention & control*; D010074:Oxandrolone / Q000627:therapeutic use; D010630:Phenindione / Q000008:administration & dosage* / Q000633:toxicity; D011239:Prednisolone / Q000627:therapeutic use; D011277:Pregnanediones / Q000627:therapeutic use; D011278:Pregnanes / Q000627:therapeutic use*; D011292:Premedication; D011374:Progesterone / Q000627:therapeutic use; D051381:Rats; D013148:Spironolactone / Q000627:therapeutic use; D013974:Thyroxine / Q000627:therapeutic use*; D014221:Triamcinolone / Q000627:therapeutic use
D000731:Androstanes; D011277:Pregnanediones; D011278:Pregnanes; D014221:Triamcinolone; D013148:Spironolactone; D003900:Desoxycorticosterone; D011374:Progesterone; D004958:Estradiol; D010630:Phenindione; D010074:Oxandrolone; D011239:Prednisolone; D005032:Ethylestrenol; D013974:Thyroxine; D004121:Dimethyl Sulfoxide